DEVELOPING DIGESTIZYME MICROSPHERES IN CYSTIC FIBROSIS

Information

  • Research Project
  • 3496096
  • ApplicationId
    3496096
  • Core Project Number
    R43DK044049
  • Full Project Number
    1R43DK044049-01
  • Serial Number
    44049
  • FOA Number
  • Sub Project Id
  • Project Start Date
    5/15/1991 - 33 years ago
  • Project End Date
    11/15/1991 - 33 years ago
  • Program Officer Name
  • Budget Start Date
    5/15/1991 - 33 years ago
  • Budget End Date
    11/15/1991 - 33 years ago
  • Fiscal Year
    1991
  • Support Year
    1
  • Suffix
  • Award Notice Date
    5/11/1991 - 33 years ago
Organizations

DEVELOPING DIGESTIZYME MICROSPHERES IN CYSTIC FIBROSIS

DESCRIPTION: (Adapted from Applicant's Abstract) The overall objective of this program is to develop high potency and stable polymer-coated digestive enzyme/bile acid-containing microspheres (DIGESTIZYME) for pancreatic enzyme deficient cystic fibrosis patients that is superior to the currently marketed digestive enzyme products. The objective of this Phase I proposal is to demonstrate the technical feasibility of preparing a high potency and stable DIGESTIZYME composition. The objective of the subsequent Phase II proposal is to demonstrate safety and clinical effectiveness of the DIGESTIZYME with pancreatic enzyme deficient cystic fibrosis patients. The specific aims of this Phase I proposal are to: 1. Investigate the compatibility and stability of high potency pancreatic enzyme powders, purchased from different manufacturers, for compatibility with bile acids and other formulation ingredients. 2. Develop prototype polymer-coated digestive enzyme/bile acid-containing microspheres. 3. Characterize the polymer-coated enzyme microspheres for integrity, enzyme potency and stability under simulated gastric and intestinal conditions. 4. Determine the kinetics of lipase, amylase, protease and bile acid release from the microspheres under simulated intestinal conditions. 5. Establish the long term stability of the polymer-coated enzyme microspheres under accelerated storage conditions.

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    R43
  • Administering IC
    DK
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    847
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    SSS
  • Study Section Name
  • Organization Name
    DIGESTIVE CARE, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    BETHLEHEM
  • Organization State
    NJ
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    18015
  • Organization District
    UNITED STATES